Neumora Therapeutics, Inc.
NMRA$63M
Micro CapNASDAQBiological Products, (No Diagnostic Substances)🇺🇸North AmericaWATERTOWN95 employees
Drugs in Pipeline
2
Phase 3 Programs
1
Upcoming Catalysts
2
Next Catalyst
Aug 5, 2026
7wMarket Overview
Stock performance and key metrics
NMRA News
Catalyst Timeline
2 upcoming, 0 past
Drug Pipeline
NMRA-335140
Major Depressive Disorder
NMRA-335140 80 mg
Major Depressive Episode Associated With Bipolar II Disorder
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NMRA-335140 | Phase 3 | Major Depressive Disorder | - | - |
NMRA-335140 80 mg | Phase 2 | Major Depressive Episode Associated With Bipolar II Disorder | - | - |
Catalyst Verdict
Market-Implied Move
Regulatory Approvals
Get Catalyst Alerts
Receive weekly digests of upcoming catalysts
Data is aggregated from public sources (FDA, SEC, ClinicalTrials.gov). While we strive for accuracy, information may be incomplete, delayed, or contain errors. Terms apply